- Home
- TEO vs BPMC Comparison
TEO vs BPMC Comparison
Compare TEO & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEO
- BPMC
- Stock Information
- Founded
- TEO 1979
- BPMC 2008
- Country
- TEO Argentina
- BPMC United States
- Employees
- TEO N/A
- BPMC N/A
- Industry
- TEO Telecommunications Equipment
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- TEO Telecommunications
- BPMC Health Care
- Exchange
- TEO Nasdaq
- BPMC Nasdaq
- Market Cap
- TEO 5.9B
- BPMC 7.0B
- IPO Year
- TEO N/A
- BPMC 2015
- Fundamental
- Price
- TEO $11.64
- BPMC $92.25
- Analyst Decision
- TEO Sell
- BPMC Buy
- Analyst Count
- TEO 1
- BPMC 19
- Target Price
- TEO $6.10
- BPMC $123.61
- AVG Volume (30 Days)
- TEO 193.0K
- BPMC 1.0M
- Earning Date
- TEO 11-07-2024
- BPMC 02-13-2025
- Dividend Yield
- TEO 2.49%
- BPMC N/A
- EPS Growth
- TEO N/A
- BPMC N/A
- EPS
- TEO 0.21
- BPMC N/A
- Revenue
- TEO $1,780,106,477.00
- BPMC $508,824,000.00
- Revenue This Year
- TEO $88.31
- BPMC $44.29
- Revenue Next Year
- TEO $16.92
- BPMC $32.49
- P/E Ratio
- TEO $13.47
- BPMC N/A
- Revenue Growth
- TEO N/A
- BPMC 104.04
- 52 Week Low
- TEO $5.52
- BPMC $80.68
- 52 Week High
- TEO $15.54
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- TEO 46.40
- BPMC 34.05
- Support Level
- TEO $10.50
- BPMC $90.84
- Resistance Level
- TEO $11.32
- BPMC $96.78
- Average True Range (ATR)
- TEO 0.71
- BPMC 4.34
- MACD
- TEO 0.04
- BPMC -2.26
- Stochastic Oscillator
- TEO 65.32
- BPMC 5.64
About TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services) and the United States (fixed wholesale services).
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.